Lista de obras - Carmen Ghilardi - Dominio Público Uruguay

A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing

artículo científico publicado en 2019

Anticancer therapy with angiogenesis inhibitors.

artículo científico publicado en 2001

Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists.

artículo científico publicado en 2017

Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle

artículo científico publicado en 2016

Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis

artículo científico publicado en 2010

Erratum to: Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists.

artículo científico publicado en 2017

Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts

article

Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium

artículo científico publicado en 2008

Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.

artículo científico publicado en 2012

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

artículo científico publicado en 2014

Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells.

artículo científico publicado en 2000

Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype

artículo científico publicado en 2009

Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment

artículo científico publicado en 2011

Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.

artículo científico publicado en 2015

The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically

artículo científico publicado en 2003

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.